Ashok Muthukrishnan, MD
Nuclear Radiology · Pittsburgh, PANPI 1588618938
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Novartis at 33.8% of the total. 2025 is the largest year on record at $11,162, more than ten times the $267 reported in 2022.
Across 54 payments — averaging $236.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$4K
- Lantheus Medical Imaging, Inc.$4K
- Telix Pharmaceuticals$3K
- United Imaging Healthcare North America LLC$307
- Siemens Medical Solutions USA, Inc.$278
- Progenics Pharmaceuticals, Inc.$167
- plus $326 from 5 others
Across 9 payments — averaging $10,200 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lantheus Medical Imaging, Inc.$55K
- Progenics Pharmaceuticals, Inc.$37K
What the payments were for
- Consulting fees$3,71329%
- Speaking & faculty fees$4,22533%
- Travel & lodging$2,21117%
- Food & beverage$2,60320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $4,309 |
| Lantheus Medical Imaging, Inc. | 1 | $4,225 |
| Telix Pharmaceuticals | 15 | $3,139 |
| United Imaging Healthcare North America LLC | 1 | $307 |
| Siemens Medical Solutions USA, Inc. | 3 | $278 |
| Progenics Pharmaceuticals, Inc. | 3 | $167 |
| Lilly USA, LLC | 2 | $139 |
| GE HealthCare | 3 | $64 |
| Blue Earth Diagnostics | 2 | $46 |
| Voximetry, Inc. | 1 | $39 |
| Life Molecular Imaging Ltd | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$3,041
- uMI Panorama,uMI 550$307
- Biograph Vision 600 (8 Ring/64 CT)$253
- Lutathera$102
- PLUVICTO$102
How this compares
Too few nuclear radiology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $262 |
Paid to pharmacies, not to this prescriber.
Other nuclear radiology in Pittsburgh
- Shanteri NayakPittsburgh$165
- Charles IntenzoPhiladelphia$85K
- Jacob DubroffPhiladelphia$9K
- Jian YuPhiladelphia$8K
- Robert FournierBethlehem$3K
- Kevin SchlegelDanville$1K
- Mark SellmyerPhiladelphia$676
- Luis AraujoPhiladelphia$227
- George EdeburnWashington Crossing$225
- Bhishak KamatPhiladelphia$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.